Perkins Capital Management Inc holds a focused book of 79 stocks worth $133.0M as of Q2 2026 (disclosed Jul 24, 2026, a ~45-day 13F lag). This quarter they opened Creative Realities Inc and trimmed Natera Inc. Their largest long position is Natera Inc at 8% of the equity book. Cloning the disclosed picks since 2024 would be +57% (+29.4%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/884300/holdings"
Use Arkolith to show PERKINS CAPITAL MANAGEMENT INC's latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 18.0 points over this window.
Growth of $10,000 cloning Perkins Capital Management Inc's disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
99% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Perkins Capital Management Inc
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 76 / 79 | $863.1B |
| GEODE CAPITAL MANAGEMENT, LLC | 76 / 79 | $264.8B |
| UBS Group AG | 76 / 79 | $46.0B |
| VANGUARD CAPITAL MANAGEMENT LLC | 73 / 79 | $684.4B |
| MORGAN STANLEY | 73 / 79 | $182.1B |
| VANGUARD FIDUCIARY TRUST CO | 73 / 79 | $60.4B |
| STATE STREET CORP | 72 / 79 | $465.7B |
| NORTHERN TRUST CORP | 72 / 79 | $114.8B |
Ranked by how many of Perkins Capital Management Inc's top 79 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Natera Inc COM | $11.0M | 40.6K | 8.3% | ▼−8.3% Reduced · −4K sh | |
| 2 | Eli Lilly & Co COM | $10.4M | 8.7K | 7.8% | ▼−1.7% Reduced · −150 sh | |
| 3 | Advanced Micro Devices Inc Del COM | $8.1M | 13.9K | 6.1% | ▼−10% Reduced · −2K sh | |
| 4 | Butterfly Network Inc COM | $7.3M | 867.6K | 5.5% | ▼−6.8% Reduced · −63K sh | |
| 5 | Axogen Inc COM | $6.8M | 147.8K | 5.1% | ▼−12% Reduced · −21K sh | |
| 6 | Inuvo Inc COM | $6.5M | 515.0K | 4.9% | ▼−12% Reduced · −67K sh | |
| 7 | Quicklogic Corp COM NEW | $5.1M | 257.6K | 3.9% | ▼−16% Reduced · −49K sh | |
| 8 | Idexx Labs Inc COM | $5.1M | 9.7K | 3.8% | —Held | |
| 9 | Backblaze Inc COM CL A | $4.9M | 308.7K | 3.7% | ▼−8.9% Reduced · −30K sh | |
| 10 | Microsoft Corp COM | $4.2M | 11.2K | 3.1% | ▼−2.1% Reduced · −242 sh | |
| 11 | Veracyte Inc COM | $3.5M | 60.0K | 2.6% | ▼−20% Reduced · −15K sh | |
| 12 | Ooma Inc COM | $3.4M | 177.0K | 2.6% | ▼−2.4% Reduced · −4K sh | |
| 13 | Personalis Inc COM | $3.2M | 239.0K | 2.4% | —Held | |
| 14 | Cryoport Inc COM PAR $0.001 | $3.1M | 199.9K | 2.4% | ▼−1.6% Reduced · −3K sh | |
| 15 | Ciena Corp COM NEW | $3.1M | 6.3K | 2.3% | —Held | |
| 16 | Lemaitre Vascular Inc COM | $2.4M | 25.3K | 1.8% | ▼−1.9% Reduced · −480 sh | |
| 17 | Magnite Inc COM | $1.9M | 98.6K | 1.4% | ▼−17% Reduced · −21K sh | |
| 18 | Abbott Laboratories COM | $1.8M | 20.3K | 1.4% | ▼−1.9% Reduced · −402 sh | |
| 19 | Usio Inc COM | $1.7M | 700.4K | 1.3% | ▼−0.2% Reduced · −2K sh | |
| 20 | Ondas Holdings COM NEW | $1.7M | 201.5K | 1.2% | ▼−0.2% Reduced · −500 sh | |
| 21 | Neogenomics Inc COM NEW | $1.6M | 110.0K | 1.2% | ▼−17% Reduced · −22K sh | |
| 22 | Perion Network Ltd SHS NEW | $1.6M | 165.2K | 1.2% | ▲+5.3% Added · +8K sh | |
| 23 | Neogen Corp COM | $1.6M | 177.5K | 1.2% | ▼−0.3% Reduced · −500 sh | |
| 24 | Crexendo Inc COM | $1.6M | 212.8K | 1.2% | ▲+9.2% Added · +18K sh | |
| 25 | Alphatec Hldgs Inc COM NEW | $1.5M | 175.2K | 1.1% | ▲+1.9% Added · +3K sh | |
| 26 | Abbvie Inc COM | $1.3M | 5.3K | 1.0% | ▼−0.7% Reduced · −35 sh | |
| 27 | Creative Realities Inc COM | $1.2M | 300.1K | 0.9% | ▲New New position | |
| 28 | Lucid Diagnostics Inc COM | $1.2M | 1.13M | 0.9% | ▼−0.1% Reduced · −1K sh | |
| 29 | Codexis Inc COM | $1.2M | 526.1K | 0.9% | ▼−0.3% Reduced · −1K sh | |
| 30 | Zeta Global Holdings Corp CL A | $1.1M | 55.9K | 0.8% | —Held | |
| 31 | Trisalus Life Sciences Inc COM | $1.1M | 235.1K | 0.8% | ▲+2.2% Added · +5K sh | |
| 32 | Tela Bio Inc COM | $1.0M | 1.38M | 0.8% | ▼−3.0% Reduced · −43K sh | |
| 33 | Biodesix Inc COM | $1.0M | 44.6K | 0.8% | ▼−0.4% Reduced · −165 sh | |
| 34 | Safe Pro Group Inc COM | $998K | 230.5K | 0.8% | ▼−0.3% Reduced · −750 sh | |
| 35 | Merck & Co Inc COM | $964K | 7.5K | 0.7% | ▼−3.2% Reduced · −250 sh | |
| 36 | Gilead Sciences Inc COM | $912K | 7.2K | 0.7% | —Held | |
| 37 | Viatris Inc COM | $855K | 53.8K | 0.6% | ▼−1.9% Reduced · −1K sh | |
| 38 | Pfizer Inc COM | $813K | 33.8K | 0.6% | ▼−6.0% Reduced · −2K sh | |
| 39 | Blacksky Technology Inc CL A NEW | $803K | 28.8K | 0.6% | —Held | |
| 40 | Apple Inc COM | $767K | 2.6K | 0.6% | —Held | |
| 41 | Profound Med Corp COM NEW | $760K | 114.3K | 0.6% | —Held | |
| 42 | US Bancorp COM NEW | $746K | 12.3K | 0.6% | ▼−1.6% Reduced · −200 sh | |
| 43 | Neuroone Med Technologies Co COM | $744K | 244.7K | 0.6% | ▲New New position | |
| 44 | Vida Global Inc COM | $700K | 250.0K | 0.5% | ▲New New position | |
| 45 | Target Corp COM | $620K | 4.8K | 0.5% | ▼−3.1% Reduced · −150 sh | |
| 46 | Owlet Inc CL A NEW | $611K | 106.5K | 0.5% | ▲+0.4% Added · +400 sh | |
| 47 | Elauwit Connection Inc COM | $598K | 55.5K | 0.4% | —Held | |
| 48 | Mdxhealth Sa SHS NEW | $580K | 1.41M | 0.4% | ▼−4.4% Reduced · −65K sh | |
| 49 | Seagate Technology Hldgs PL ORD SHS | $507K | 525 | 0.4% | ▼−4.5% Reduced · −25 sh | |
| 50 | Atricure Inc COM | $490K | 17.5K | 0.4% | ▼−33% Reduced · −9K sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 24, 2026 | 79 | $133.0M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 23, 2026 | 86 | $106.7M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 4, 2026 | 91 | $125.9M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 31, 2025 | 83 | $113.5M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 7, 2025 | 83 | $99.5M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 7, 2025 | 82 | $94.8M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 11, 2025 | 81 | $112.7M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 31, 2024 | 84 | $106.6M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.